RecruitingNCT06345690
VIA Disc NP Registry 3.0
Sponsor
VIVEX Biologics, Inc.
Enrollment
500 participants
Start Date
Feb 27, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Willing to sign the informed consent and deemed capable of complying with the requirements of the study protocol
- 18 years of age or older
- Literate, able to speak and read English, and able to complete questionnaires independently
- Subject received a VIA Disc NP injection with 1 or more levels within 90 days of the baseline visit.
Exclusion Criteria4
- Participant did not receive VIA Disc NP injection
- Participant is pregnant (self-reported, no special study pregnancy testing needed).
- Any contraindications as noted in the VIA Disc NP Instructions for Use
- Previous treatment with VIA Disc NP
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERVIA Disc NP
VIA Disc NP - Allograft tissue injection
Locations(26)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06345690
Related Trials
Erector Spinae Plane Block Versus Trigger Point Injection for Chronic Thoracic Myofascial Pain
NCT076328205 locations
Efficacy of the Erector Spinae Plane Block for Persistent Back Pain in Patients With Ankylosing Spondylitis
NCT076337301 location
Brain Mechanisms Supporting Cannabis-induced Pain Relief
NCT049829651 location
Hormones, Outcomes, and Pain Pathways in Exercise Study
NCT075791821 location
Treatment of Acute Low Back Pain With Transcutaneous Electrical Neurostimulation in Emergency Departments
NCT075884901 location